questionsmedicales.fr
Maladies cardiovasculaires
Maladies vasculaires
Embolie et thrombose
Thrombose
Thrombose veineuse
Syndrome de Budd-Chiari
Syndrome de Budd-Chiari : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Syndrome de Budd-Chiari
Échographie
Imagerie par résonance magnétique
Tests sanguins
Fonction hépatique
Coagulation
Ascite
Douleur abdominale
Hypertrophie hépatique
Échographie Doppler
Flux sanguin
Obstruction veineuse
Biopsie hépatique
Lésions hépatiques
Diagnostic différentiel
Symptômes
5
Douleur abdominale
Syndrome de Budd-Chiari
Hépatomégalie
Ascite
Hypertension portale
Cavité abdominale
Jaunisse
Bilirubine
Syndrome de Budd-Chiari
Asymptomatique
Syndrome de Budd-Chiari
Forme chronique
Prévention
5
Prévention
Troubles de la coagulation
Obésité
Anticoagulants
Prévention
Thromboses
Habitudes de vie
Alimentation équilibrée
Exercice
Vaccination
Hépatite
Complications hépatiques
Surveillance
Maladies hépatiques
Troubles de la coagulation
Traitements
5
Anticoagulants
Transplantation hépatique
Procédures endovasculaires
Anticoagulants
Thrombose veineuse
Complications
Procédure endovasculaire
Angioplastie
Stenting
Transplantation hépatique
Insuffisance hépatique
Complications
Traitements symptomatiques
Diurétiques
Ascite
Complications
5
Complications
Insuffisance hépatique
Hypertension portale
Insuffisance hépatique
Syndrome de Budd-Chiari
Complications
Hypertension portale
Veine porte
Obstruction
Complications à long terme
Cirrhose
Syndrome de Budd-Chiari
Prévention
Traitement précoce
Surveillance
Facteurs de risque
5
Facteurs de risque
Troubles de la coagulation
Obésité
Obésité
Syndrome de Budd-Chiari
Facteurs de risque
Maladies hépatiques
Cirrhose
Syndrome de Budd-Chiari
Contraceptifs oraux
Thrombose
Facteurs de risque
Tabagisme
Problèmes vasculaires
Thrombose
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome de Budd-Chiari : Questions médicales les plus fréquentes",
"headline": "Syndrome de Budd-Chiari : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome de Budd-Chiari : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-11",
"dateModified": "2025-04-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome de Budd-Chiari"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Thrombose veineuse",
"url": "https://questionsmedicales.fr/mesh/D020246",
"about": {
"@type": "MedicalCondition",
"name": "Thrombose veineuse",
"code": {
"@type": "MedicalCode",
"code": "D020246",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.355.830.925"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Budd-Chiari",
"alternateName": "Budd-Chiari Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D006502",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None Shalimar",
"url": "https://questionsmedicales.fr/author/None%20Shalimar",
"affiliation": {
"@type": "Organization",
"name": "Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India."
}
},
{
"@type": "Person",
"name": "Akash Shukla",
"url": "https://questionsmedicales.fr/author/Akash%20Shukla",
"affiliation": {
"@type": "Organization",
"name": "Department of Gastroenterology, Seth Gordhandas Sunderdas Medical College and King Edward Memorial Hospital, Mumbai, 400012, India."
}
},
{
"@type": "Person",
"name": "Joseph J Alukal",
"url": "https://questionsmedicales.fr/author/Joseph%20J%20Alukal",
"affiliation": {
"@type": "Organization",
"name": "Institute of Digestive Health & Liver Diseases, Mercy Medical Center, Baltimore, MD, USA."
}
},
{
"@type": "Person",
"name": "Talan Zhang",
"url": "https://questionsmedicales.fr/author/Talan%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Institute of Digestive Health & Liver Diseases, Mercy Medical Center, Baltimore, MD, USA."
}
},
{
"@type": "Person",
"name": "Paul J Thuluvath",
"url": "https://questionsmedicales.fr/author/Paul%20J%20Thuluvath",
"affiliation": {
"@type": "Organization",
"name": "Institute of Digestive Health & Liver Diseases, Mercy Medical Center, Baltimore, MD, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Anal canal gastrointestinal stromal tumour (GIST).",
"datePublished": "2023-04-07",
"url": "https://questionsmedicales.fr/article/37028821",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bcr-2023-255040"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of four assays for human papillomavirus detection in the anal canal.",
"datePublished": "2022-07-06",
"url": "https://questionsmedicales.fr/article/35809783",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cmi.2022.06.027"
}
},
{
"@type": "ScholarlyArticle",
"name": "Multimode ultrasound imaging of an anal canal gastrointestinal stromal tumour (GIST).",
"datePublished": "2024-05-27",
"url": "https://questionsmedicales.fr/article/38801613",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10151-024-02934-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Anal canal and sphincter function in children with Hirschsprung disease after definitive surgery.",
"datePublished": "2022-10-21",
"url": "https://questionsmedicales.fr/article/36384936",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jpedsurg.2022.10.031"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characteristics of anal canal squamous cell carcinoma as an HPV-associated cancer in Japan.",
"datePublished": "2023-04-28",
"url": "https://questionsmedicales.fr/article/37115427",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10147-023-02339-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies cardiovasculaires",
"item": "https://questionsmedicales.fr/mesh/D002318"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies vasculaires",
"item": "https://questionsmedicales.fr/mesh/D014652"
},
{
"@type": "ListItem",
"position": 4,
"name": "Embolie et thrombose",
"item": "https://questionsmedicales.fr/mesh/D016769"
},
{
"@type": "ListItem",
"position": 5,
"name": "Thrombose",
"item": "https://questionsmedicales.fr/mesh/D013927"
},
{
"@type": "ListItem",
"position": 6,
"name": "Thrombose veineuse",
"item": "https://questionsmedicales.fr/mesh/D020246"
},
{
"@type": "ListItem",
"position": 7,
"name": "Syndrome de Budd-Chiari",
"item": "https://questionsmedicales.fr/mesh/D006502"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome de Budd-Chiari - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome de Budd-Chiari",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome de Budd-Chiari",
"description": "Comment diagnostiquer le syndrome de Budd-Chiari ?\nQuels tests sanguins sont utiles ?\nQuels signes cliniques indiquent ce syndrome ?\nL'échographie Doppler est-elle utile ?\nQuand envisager une biopsie hépatique ?",
"url": "https://questionsmedicales.fr/mesh/D006502?mesh_terms=Anal+Canal#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome de Budd-Chiari",
"description": "Quels sont les symptômes courants ?\nLa douleur abdominale est-elle fréquente ?\nQu'est-ce que l'ascite ?\nLa jaunisse est-elle un symptôme ?\nPeut-on avoir des symptômes asymptomatiques ?",
"url": "https://questionsmedicales.fr/mesh/D006502?mesh_terms=Anal+Canal#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome de Budd-Chiari",
"description": "Comment prévenir le syndrome de Budd-Chiari ?\nLes anticoagulants peuvent-ils prévenir ce syndrome ?\nQuelles habitudes de vie adopter ?\nLes vaccinations sont-elles importantes ?\nFaut-il surveiller les maladies hépatiques ?",
"url": "https://questionsmedicales.fr/mesh/D006502?mesh_terms=Anal+Canal#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome de Budd-Chiari",
"description": "Quels traitements sont disponibles ?\nQuand utiliser des anticoagulants ?\nQu'est-ce qu'une procédure endovasculaire ?\nQuand envisager une transplantation hépatique ?\nY a-t-il des traitements symptomatiques ?",
"url": "https://questionsmedicales.fr/mesh/D006502?mesh_terms=Anal+Canal#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome de Budd-Chiari",
"description": "Quelles sont les complications possibles ?\nL'insuffisance hépatique est-elle fréquente ?\nQu'est-ce que l'hypertension portale ?\nPeut-on avoir des complications à long terme ?\nLes complications peuvent-elles être évitées ?",
"url": "https://questionsmedicales.fr/mesh/D006502?mesh_terms=Anal+Canal#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome de Budd-Chiari",
"description": "Quels sont les principaux facteurs de risque ?\nL'obésité augmente-t-elle le risque ?\nLes maladies hépatiques sont-elles un risque ?\nLes contraceptifs oraux sont-ils un facteur ?\nLe tabagisme influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D006502?mesh_terms=Anal+Canal#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer le syndrome de Budd-Chiari ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'échographie, l'IRM et des tests sanguins pour évaluer la fonction hépatique."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utiles ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent les marqueurs de la fonction hépatique et les tests de coagulation."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent ce syndrome ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent l'ascite, la douleur abdominale et l'hypertrophie du foie."
}
},
{
"@type": "Question",
"name": "L'échographie Doppler est-elle utile ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet d'évaluer le flux sanguin dans les veines hépatiques et de détecter des obstructions."
}
},
{
"@type": "Question",
"name": "Quand envisager une biopsie hépatique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une biopsie peut être envisagée si le diagnostic est incertain ou pour évaluer des lésions hépatiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, douleur abdominale, jaunisse et ascite."
}
},
{
"@type": "Question",
"name": "La douleur abdominale est-elle fréquente ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur abdominale est un symptôme fréquent, souvent localisée dans la partie supérieure droite."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que l'ascite ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'ascite est l'accumulation de liquide dans la cavité abdominale, souvent causée par une hypertension portale."
}
},
{
"@type": "Question",
"name": "La jaunisse est-elle un symptôme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la jaunisse, due à une accumulation de bilirubine, est un symptôme courant du syndrome."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes asymptomatiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent être asymptomatiques, surtout dans les formes chroniques."
}
},
{
"@type": "Question",
"name": "Comment prévenir le syndrome de Budd-Chiari ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut la gestion des facteurs de risque comme les troubles de la coagulation et l'obésité."
}
},
{
"@type": "Question",
"name": "Les anticoagulants peuvent-ils prévenir ce syndrome ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anticoagulants peuvent prévenir les thromboses chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Quelles habitudes de vie adopter ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter une alimentation équilibrée, faire de l'exercice et éviter le tabac sont bénéfiques."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, se faire vacciner contre l'hépatite peut réduire le risque de complications hépatiques."
}
},
{
"@type": "Question",
"name": "Faut-il surveiller les maladies hépatiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, surveiller les maladies hépatiques et les troubles de la coagulation est crucial pour la prévention."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des anticoagulants, des procédures endovasculaires et, dans certains cas, une transplantation hépatique."
}
},
{
"@type": "Question",
"name": "Quand utiliser des anticoagulants ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants sont utilisés pour traiter les thromboses veineuses hépatiques et prévenir les complications."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'une procédure endovasculaire ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une intervention pour débloquer les veines hépatiques, souvent par angioplastie ou stenting."
}
},
{
"@type": "Question",
"name": "Quand envisager une transplantation hépatique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La transplantation est envisagée en cas d'insuffisance hépatique sévère ou de complications irréversibles."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements symptomatiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements symptomatiques comme les diurétiques peuvent aider à gérer l'ascite."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'insuffisance hépatique, la thrombose et l'hypertension portale."
}
},
{
"@type": "Question",
"name": "L'insuffisance hépatique est-elle fréquente ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'insuffisance hépatique est une complication grave pouvant survenir dans ce syndrome."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que l'hypertension portale ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypertension portale est une augmentation de la pression dans la veine porte, causée par l'obstruction."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des complications à long terme ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications à long terme comme la cirrhose peuvent se développer si non traitées."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par un traitement précoce et une surveillance régulière."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent les troubles de la coagulation, l'obésité, et certaines maladies hépatiques."
}
},
{
"@type": "Question",
"name": "L'obésité augmente-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité est un facteur de risque connu pour le syndrome de Budd-Chiari."
}
},
{
"@type": "Question",
"name": "Les maladies hépatiques sont-elles un risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies hépatiques, comme la cirrhose, augmentent le risque de ce syndrome."
}
},
{
"@type": "Question",
"name": "Les contraceptifs oraux sont-ils un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'utilisation prolongée de contraceptifs oraux peut augmenter le risque de thrombose."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut contribuer à des problèmes vasculaires, augmentant le risque de thrombose."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 06/04/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
Publications dans "Syndrome de Budd-Chiari" :
4 publications dans cette catégorie
Affiliations :
Department of Gastroenterology, Seth Gordhandas Sunderdas Medical College and King Edward Memorial Hospital, Mumbai, 400012, India.
Publications dans "Syndrome de Budd-Chiari" :
3 publications dans cette catégorie
Affiliations :
Institute of Digestive Health & Liver Diseases, Mercy Medical Center, Baltimore, MD, USA.
Publications dans "Syndrome de Budd-Chiari" :
3 publications dans cette catégorie
Affiliations :
Institute of Digestive Health & Liver Diseases, Mercy Medical Center, Baltimore, MD, USA.
Publications dans "Syndrome de Budd-Chiari" :
3 publications dans cette catégorie
Affiliations :
Institute of Digestive Health & Liver Diseases, Mercy Medical Center, Baltimore, MD, USA.
Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Publications dans "Syndrome de Budd-Chiari" :
3 publications dans cette catégorie
Affiliations :
Department of Radiodiagnosis, All India Institute of Medical Sciences, New Delhi, India.
Publications dans "Syndrome de Budd-Chiari" :
3 publications dans cette catégorie
Affiliations :
Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, 110 029, India.
Publications dans "Syndrome de Budd-Chiari" :
2 publications dans cette catégorie
Affiliations :
Department of Interventional Radiology, The Affiliated Hospital of XuZhou Medical University, Province Jiangsu, PR China.
Publications dans "Syndrome de Budd-Chiari" :
2 publications dans cette catégorie
Affiliations :
Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
Publications dans "Syndrome de Budd-Chiari" :
2 publications dans cette catégorie
Affiliations :
Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
Publications dans "Syndrome de Budd-Chiari" :
2 publications dans cette catégorie
Affiliations :
Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
Publications dans "Syndrome de Budd-Chiari" :
2 publications dans cette catégorie
Affiliations :
College of Medicine and Biological Information Engineering, Northeastern University, Shenyang, China.
Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, China.
Department of Life Sciences and Biopharmaceutis, Shenyang Pharmaceutical University, Shenyang, China.
Publications dans "Syndrome de Budd-Chiari" :
2 publications dans cette catégorie
Affiliations :
Department of Radiology, Seth Gordhandas Sunderdas Medical College and King Edward Memorial Hospital, Mumbai, 400012, India.
Publications dans "Syndrome de Budd-Chiari" :
2 publications dans cette catégorie
Affiliations :
Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, 110 029, India.
Publications dans "Syndrome de Budd-Chiari" :
2 publications dans cette catégorie
Affiliations :
Department of Gastroenterology, All India Institute of Medical Sciences, Patna 801507, India.
Publications dans "Syndrome de Budd-Chiari" :
2 publications dans cette catégorie
Affiliations :
Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi 110029, Delhi, India.
Publications dans "Syndrome de Budd-Chiari" :
2 publications dans cette catégorie
Affiliations :
Department of Gastroenterology, Seth G S Medical College and KEM Hospital, Parel, Mumbai, 400012, India.
Publications dans "Syndrome de Budd-Chiari" :
1 publication dans cette catégorie
Affiliations :
Department of Interventional Radiology, The Affiliated Hospital of XuZhou Medical University, Province Jiangsu, PR China.
Publications dans "Syndrome de Budd-Chiari" :
1 publication dans cette catégorie
Affiliations :
Department of Interventional Radiology, The Affiliated Hospital of XuZhou Medical University, Province Jiangsu, PR China.
Publications dans "Syndrome de Budd-Chiari" :
1 publication dans cette catégorie
Affiliations :
Department of Interventional Radiology, The Affiliated Hospital of XuZhou Medical University, Province Jiangsu, PR China.
Publications dans "Syndrome de Budd-Chiari" :
SummaryGastrointestinal stromal tumours (GISTs) are malignant mesenchymal tumours that originate from the interstitial pacemaker cells of Cajal. They are particularly rare, comprising only 5% of all G...
Anal cancer is preceded by high-risk human papillomavirus (HRHPV) infection, predominantly HPV16. No HPV assay is licenced for use in anal screening. We aimed to determine the sensitivity and specific...
In a cohort of Australian HIV-positive and negative gay and bisexual men, we compared the sensitivity and specificity of detection of 13 anal HRHPV genotypes by Linear Array (LA), Cobas 4800, EuroArra...
A total of 475 participants had baseline results available for all four assays (166, 35.0% HIV positive), and 169 participants had a diagnosis of cytological and/or histological HSIL. The HPV16 and an...
Anyplex II HPV28 and EuroArray detected more non-16 HRHPV genotypes than LA. Increasing the Anyplex II HPV28 cutoff improved specificity without compromising sensitivity for detection of concurrent HS...
Gastrointestinal stromal tumours (GISTs) can develop throughout the entire gastrointestinal tract, but these tumours are usually found in the stomach and small intestine. In this case, a rare GIST ari...
Anorectal manometry may be useful to objectively evaluate anorectal function following definitive pullthrough for Hirschsprung Disease (HD) but there is little published data. Our study aims to invest...
This was a prospective observational study. Convenience sampling method was used to recruit all HD patients who had definitive pullthrough from January 2019 to December2020 in our institution. High-re...
There were 32 participants (30 boys). Median age at participation was 26.5 months (range: 13.8-156). Twenty-four (75%) had transanal pullthrough, 8(25%) underwent Duhamel procedure. PICSS scored 10(31...
Bowel function does not appear to be significantly associated with HRAM findings after definitive pullthrough for HD, but our study is limited by small sample size. RAIR was present in 37.5% patients ...
Level II....
The definition of the anal canal was revised in the TNM classification (8th edition). The Japanese Society for Cancer of the Colon and Rectum (JSCCR) conducted a retrospective multi-institutional stud...
The surgical treatment of inguinal lymph node (ILN) metastases secondary to anorectal adenocarcinoma remains controversial. This study aimed to clarify the surgical treatment and management of ILN met...
This retrospective, multi-centre, observational study included patients with synchronous or metachronous ILN metastases who were diagnosed with rectal or anal canal adenocarcinoma between January 1997...
Among 1181 consecutively enrolled patients who received treatment for rectal or anal canal adenocarcinoma at 20 referral hospitals, 76 (6.4%) and 65 (5.5%) had synchronous and metachronous ILN metasta...
The ILN can be appropriately classified as a regional lymph node in rectal and anal canal adenocarcinoma. Moreover, aggressive ILN dissection might be effective in improving the prognosis of low recta...
Condyloma acuminatum (CA) of the anal canal is difficult to treat and subject to relapse.. We investigated the effects of aminolevulinic acid-based photodynamic therapy (ALA-PDT) combined with oral ac...
A total of 101 patients diagnosed with intra-anal CA were enrolled. All patients underwent liquid nitrogen cryotherapy as a basic treatment until visible wart clearance. Patients were divided into two...
The cure rate in the ALA-PDT plus acitretin group was 94% (47/50), which was significantly higher than 80.4% (41/51) in ALA-PDT group. The recurrence rate in the ALA-PDT plus acitretin group was 6% (3...
ALA-PDT combined with oral acitretin is effective and safe in the treatment of refractory CA in anal canal, and with further study may become an option for these patients....
Anal canal cancer (ACC) is uncommon. The gold standard of care is chemoradiotherapy treatment. However, this treatment is associated with considerable acute and late side effects. The aim of this pilo...
Sixteen patients were recruited to this prospective observational study from March 2015 to December 2017. All patients received volumetric modulated arc therapy (VMAT) in 30#. Toxicity data were grade...
The majority of toxicity and PRO items peaked in severity at the end of treatment (week 6). Skin was the only item where >50% of patients had ≥ grade 2 toxicity at any point with 75% having ≥ grade 2 ...
After reaching their maximum severity at the end of treatment, the majority of toxicity and PRO items approached baseline levels by 3-month post-treatment. The results of this study suggest that PROs ...
Carcinosarcomas are biphasic malignant neoplasms and are rare outside the corpus uteri. Here we report a carcinosarcoma arising in the anal canal in a 60 year-old female. This is only the fourth repor...
Patients with T2N0 squamous cell carcinoma of the anal canal (SCCA) have comprised less than 30% of patients enrolled in phase III clinical trials of curative-intent definitive chemoradiation. We aime...
Retrospective multicenter study of patients with T2N0 SCCA, with the primary endpoint to compare the progression-free survival (PFS) of patients treated with full definitive chemoradiotherapy (f-CRT, ...